Antihemophilic factor, human recombinant
- Generic Name
- Antihemophilic factor, human recombinant
- Brand Names
- Advate, Adynovate, Helixate, Kogenate, Kovaltry, Novoeight, Recombinate
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 139076-62-3
- Unique Ingredient Identifier
- P89DR4NY54
- Background
Human recombinant antihemophilic factor (AHF) or Factor VIII, 2332 residues, glycosylated, produced by CHO cells
- Indication
The human recombinant antihemophilic factor is indicated for use in adults and children with hemophilia A for the control and prevention of bleeding episodes, perioperative management, and routine prophylaxis to prevent or reduce the frequency of bleeding episodes.
- Associated Conditions
- Bleeding, Joint Damage, Perioperative Blood Loss
- Associated Therapies
- -
No trials found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath